Open AccessMetabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
Author(s) -
Corey Lager,
Nazanene H. Esfandiari,
Yingying Luo,
Angela Subauste,
Andrew Kraftson,
Morton B. Brown,
Oliver A. Varban,
Rasimcan Meral,
Ruth Cassidy,
Catherine Nay,
Amy Lockwood,
Darlene Bellers,
Colleen M. Buda,
Elif A Oral
Publication year - 2018
Publication title -
obesity surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 138
eISSN - 1708-0428
pISSN - 0960-8923
DOI - 10.1007/s11695-018-3346-1
Subject(s) - medicine , weight loss , sleeve gastrectomy , hyperlipidemia , diabetes mellitus , roux en y anastomosis , discontinuation , surgery , gastric bypass , dyslipidemia , obesity , endocrinology
Sleeve gastrectomy (LSG) is now the predominant bariatric surgery performed, yet there is limited long-term data comparing important outcomes between LSG and Roux-en-Y gastric bypass (RYGB). This study compares weight loss and impact on comorbidities of the two procedures.